These compounds may interact with:
Coagulation factor X
Potentially involved in: factor x deficiency; carcinoma; carney complex; atrial fibrillation; pulmonary embolism; doyne honeycomb retinal dystrophy; thrombophilia; chromosome 2p16.1-p15 deletion syndrome; cerebrovascular disease; cancer; cystinuria; coronary artery disease; autistic disorder; antiphospholipid syndrome; intellectual disability; hemophilia b; blood coagulation disorders; epistaxis; gingival hemorrhage; hemarthrosis
Disease data sourced from Pharos.